Abstract
Objective To study the effect of triptolide combined with cisplatin on immune function and angiogenesis of bladder cancer (T24) cells-bearing nude mice. Methods Eighteen bladder cancer (T24) cells-bearing nude mice were divided into control group, cisplatin group, and combination group, respectively given intraperitoneal injection of 0.9% sodium chloride solution, cisplatin, and triptolide+ cisplatin. Flow cytometry was used to detect fluoresceine isothiocyanate (FITC)-dexran positive rate of abdominal macrophages, enzyme linked immunosorbent assay (ELISA) to determine interleukin (IL)-1 and tumor necrosis factor-α (TNF-α) expression levels in the abdominal macrophages, and immunohistochemical staining to examine vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and microvessel density (MVD) expression levels. Results The positive rate of FITC-dexran, CD11b-FITC, and CD68-FITC in abdominal macrophages of combination group was significantly higher than that in cisplatin group [(11.74±1.25)% vs. (7.24±0.84)%, (33.33±3.46)% vs. (21.84±2.45)%, and (33.89±4.12)% vs. (20.52±2.32)%] (t=9.639-7.319, P<0.05). The IL-1 and TNF-α expression levels in combination group were significantly higher than those in cisplatin group [(40.92±3.86) vs. (26.05±3.01) pg/ml, and (55.78±6.25) vs. (38.42±5.26) pg/ml] (t=5.201-7.441, P<0.05). The VEGF, bFGF, and MVD expression levels in combination group were significantly lower than those in cisplatin group (1.24±0.48 vs. 1.88±0.52, 0.88±0.43 vs. 1.51±0.56, and 3.11±1.49 vs. 8.15±3.00) (t=2.186-3.686, P<0.05). Conclusion Triptolide combined with cisplatin can improve phagocytosis function and immune function of abdominal macrophages in bladder cancer (T24) cells-bearing nude mice, and reduce VEGF and bFGF expression levels, and then inhibit growth and proliferation of tumor cells. Key words: Urinary bladder neoplasms; Triptolide; Cisplatin; Immune function; Vascular growth factors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.